ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 221 filers reported holding ALKERMES PLC in Q3 2021. The put-call ratio across all filers is 2.83 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $355,000 | +6.6% | 11,921 | -5.8% | 0.00% | 0.0% |
| Q1 2022 | $333,000 | +13.7% | 12,652 | +0.5% | 0.00% | +50.0% |
| Q4 2021 | $293,000 | -53.9% | 12,591 | -39.0% | 0.00% | -50.0% |
| Q3 2021 | $636,000 | +150.4% | 20,627 | +99.2% | 0.00% | +100.0% |
| Q2 2021 | $254,000 | +31.6% | 10,355 | +0.2% | 0.00% | 0.0% |
| Q1 2021 | $193,000 | -6.8% | 10,331 | -0.0% | 0.00% | 0.0% |
| Q4 2020 | $207,000 | +3.5% | 10,334 | -0.1% | 0.00% | -33.3% |
| Q3 2020 | $200,000 | 0.0% | 10,343 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $200,000 | +32.5% | 10,343 | -1.2% | 0.00% | 0.0% |
| Q1 2020 | $151,000 | -30.4% | 10,467 | -1.4% | 0.00% | 0.0% |
| Q4 2019 | $217,000 | -58.2% | 10,618 | -60.0% | 0.00% | -62.5% |
| Q3 2019 | $519,000 | +71.3% | 26,519 | +97.4% | 0.01% | +60.0% |
| Q2 2019 | $303,000 | – | 13,436 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 2,639,676 | $96,322,000 | 7.78% |
| Meditor Group Ltd | 892,400 | $32,564,000 | 6.11% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233,000 | $8,502,000 | 3.14% |
| Tamarack Advisers, LP | 140,000 | $5,109,000 | 2.03% |
| Asymmetry Capital Management, L.P. | 27,673 | $1,010,000 | 1.69% |
| First Light Asset Management, LLC | 211,164 | $7,705,000 | 1.00% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 304,992 | $11,129,000 | 0.85% |
| Nicollet Investment Management, Inc. | 28,020 | $1,022,000 | 0.67% |
| PRIMECAP MANAGEMENT CO/CA/ | 23,263,530 | $848,886,000 | 0.62% |
| Rhenman & Partners Asset Management AB | 120,399 | $4,393,000 | 0.51% |